Short-term intraocular pressure changes after intravitreal bevacizumab injection
Intravitreal injections of anti-vascular endothelial growth factors (anti-VEGFs) have become more popular quickly in recent years. Bevacizumab is an anti- vascular endothelial growth factor agent (anti-VEGF) used to treat choroidal neovascularization and retinal vascular disorders. Rare long lasting...
Main Authors: | Ali Dehghani, Habib Jafari, Naser Shoeibi |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2014-06-01
|
Series: | Reviews in Clinical Medicine |
Subjects: | |
Online Access: | http://rcm.mums.ac.ir/pdf_2637_408c8b79c94087715d7a9c614dcfe229.html |
Similar Items
-
The Short-Term Effect of Intravitreal Bevacizumab Injection on Intraocular Pressure
by: Şehnaz Özçalışkan, et al.
Published: (2014-10-01) -
Influence of vitreal reflux on intraocular pressure after intravitreal application of bevacizumab
by: Đogatović Nebojša, et al.
Published: (2020-01-01) -
Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity
by: Obata S, et al.
Published: (2019-12-01) -
Effect of dorzolamide-timolol fixed combination prophylaxis on intraocular pressure spikes after intravitreal bevacizumab injection
by: Sehnaz Ozcaliskan, et al.
Published: (2015-06-01) -
Effects of multiple intravitreal anti-VEGF injections on retinal nerve fiber layer and intraocular pressure:a comparative clinical study
by: Gökhan Özge, et al.
Published: (2013-04-01)